BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical hol

In the closing of the recent trading day, Amgen (AMGN) stood at $414.87, denoting a +1.82% move from

Every dividend dollar sitting in a taxable account quietly hands a portion of itself to the IRS year

These companies might bend during a downturn, but they won't break.

Farther Finance Advisors LLC raised its stake in Amgen Inc. (NASDAQ: AMGN) by 32.9% in the undefined

RBC Capital analyst Luca Issi maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the pric

Analysts raised targets for Everpure, Eli Lilly and Delek US, while cutting targets for Constellatio

Cantor Fitzgerald analyst Carter Gould maintains Amgen (NASDAQ:AMGN) with a Neutral and raises th

In the closing of the recent trading day, Amgen (AMGN) stood at $413.08, denoting a +2.6% move from

The Dow, S&P 500, and Nasdaq are all firmly in the red today as bond yields and oil prices resume th

Truist Securities analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Hold and raises the

Morgan Stanley analyst Terence Flynn maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and lowers

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wis

MassMutual Private Wealth and Trust FSB raised its position in Amgen Inc. (NASDAQ: AMGN) by 105.8% d

The Nasdaq 100 trades at records Monday, yet 55 of its 101 stocks sit below their 50-day average. QQ

Ferguson Wellman Capital Management Inc. boosted its holdings in Amgen Inc. (NASDAQ: AMGN) by 4.8% d

Argent Capital Management LLC lowered its position in shares of Amgen Inc. (NASDAQ: AMGN) by 3.5% in

Amgen offers a diversified portfolio of established therapies across oncology and inflammation suppo

October 1, 2026 records indicate that Representative David Taylor filed a purchase of Amgen (NASDAQ:

Amgen (AMGN) closed at $407.27 in the latest trading session, marking a -3.38% move from the prior d

LLY and Novo face off at EASD as new data fuels the GLP-1 market, while ETFs offer diversified expos

On September 29, 2026, Amgen Inc (AMGN) shares rose 1.3% to a current price of $423.64, within a 52-

Scotiabank analyst Louise Chen maintains Amgen (NASDAQ:AMGN) with a Sector Outperform and raises

Amgen just handed income investors another dividend raise, but a mountain of acquisition debt, crumb

Microsoft, Bloom Energy and Amgen highlight Zacks' latest market moves, with strong gains across Foc

It all comes down to portfolio construction -- one is logical, one isn't.

Vertex Pharmaceuticals and Amgen recently posted strong clinical trial results for promising candida

In the latest trading session, Amgen (AMGN) closed at $414.61, marking a +2.11% move from the previo

Subscribers to Schaeffer's Weekend Trader options recommendation service received this AMGN commenta

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Amgen's Phase 3 study shows dazodalibep significantly improves systemic disease activity in adul

Amgen (NASDAQ:AMGN) today announced positive topline results from the Phase 3 OASIZ 301 study evalua

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Crypto-linked equities ripped higher as Bitcoin cleared $80,000, but the S&P 500 slipped with th

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a lo

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

HSBC analyst Morten Herholdt downgrades Amgen (NASDAQ:AMGN) from Buy to Hold and lowers the price

Pyxis Oncology shares gained 9.25% after hours following a leadership update and ahead of Wednesday’

Amgen sank 9.8% Tuesday after Novartis' pelacarsen missed its Phase 3 endpoint, casting doubt on

Crude near $98 pushes the 10-year Treasury yield above 4.8% for the first time since 2023, hammering

AMGN stock dips 9% after rival drug trial misses goal. Discover Amgen key support levels, technical

AstraZeneca secured FDA approval for its breast cancer drug Etcamah and reported positive Phase 3 tr

Analysts downgraded BioNTech, Gulfport Energy, Amgen and Best Buy; price targets fell for BioNTech a

BMO Capital analyst Evan David Seigerman downgrades Amgen (NASDAQ:AMGN) from Outperform to Market

U.S. stock futures fell as Novartis plunged 12.7% after pelacarsen’s Phase III trial missed its endp

Cantor Fitzgerald analyst Carter Gould reiterates Amgen (NASDAQ:AMGN) with a Neutral and maintain

Wells Fargo analyst Mohit Bansal maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the

Amgen (NASDAQ:AMGN) today announced new findings showing Repatha® (evolocumab) reduced the risk of d

This whale alert can help traders discover the next big trading opportunities. Whales are entities w